Article

Vision-Ease Lens temporarily consolidates manufacturing efforts after fire

The Jakarta, Indonesia, ophthalmic lens manufacturing plant of Vision-Ease Lens (VEL) sustained damage from a major fire in November.

Ramsey, MN

-The Jakarta, Indonesia, ophthalmic lens manufacturing plant of Vision-Ease Lens (VEL) sustained damage from a major fire in November.

All employees were evacuated safely. Interim manufacturing operations of lenses made in Indonesia have been moved to VEL’s other manufacturing facility, in Ramsey, MN. Company officials said they expect to meet continued customer demand with existing inventory at key distribution centers.

“Our priority right now is ensuring employee and customer needs are met,” said Doug Hepper, chief executive officer, VEL. “The Jakarta facility is a vital part of our operation. We will leverage the skills and knowledge of our Jakarta employees to rebuild a world-class facility.”

VEL opened the 80,000-square-foot Jakarta facility in 1997. It was operational around the clock and employed approximately 500 employees.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.